Comment
doi: 10.1016/j.ypmed.2010.11.015.
Epub 2010 Dec 2.
The Polypill in the prevention of cardiovascular disease
Affiliations
- PMID: 21130112
- DOI: 10.1016/j.ypmed.2010.11.015
Item in Clipboard
Comment
The Polypill in the prevention of cardiovascular disease
Prev Med.
2011 Jan.
No abstract available
Comment on
-
Acceptance of a Polypill approach to prevent cardiovascular disease among a sample of U.S. physicians.Prev Med. 2011 Jan;52(1):10-5. doi: 10.1016/j.ypmed.2010.09.016. Epub 2010 Oct 8. Prev Med. 2011. PMID: 20933538 Free PMC article.
Similar articles
-
[The polypill: not an effective strategy for reduction of cardiovascular disease].Ned Tijdschr Geneeskd. 2005 Jul 30;149(31):1741. Ned Tijdschr Geneeskd. 2005. PMID: 16114291 Dutch.
-
[The polypill: optimal strategy for reduction of cardiovascular disease].Ned Tijdschr Geneeskd. 2005 Jul 30;149(31):1740. Ned Tijdschr Geneeskd. 2005. PMID: 16114290 Dutch.
-
Polypill: Can its Potential Enhancement of Efficacy Trigger New Interest?Glob Heart. 2016 Dec;11(4):469-472. doi: 10.1016/j.gheart.2016.10.020. Glob Heart. 2016. PMID: 27938845 No abstract available.
-
Polypill in cardiovascular disease: has it's time come?Indian Heart J. 2009 Jul-Aug;61(4):322-7. Indian Heart J. 2009. PMID: 20635733 Review. No abstract available.
-
[Prevention of cardiovascular diseases using a combined pharmacological approach: is there any place for a "polypill"?].Rev Med Liege. 2003 Sep;58(9):527-33. Rev Med Liege. 2003. PMID: 14626644 Review. French.
Cited by
-
Statins for COPD: a challenge to conventional beliefs?Prim Care Respir J. 2012 Mar;21(1):5-7. doi: 10.4104/pcrj.2012.00020. Prim Care Respir J. 2012. PMID: 22349920 Free PMC article. No abstract available.
-
Cardiovascular risk scores: qualitative study of how primary care practitioners understand and use them.Br J Gen Pract. 2013 Jun;63(611):e401-7. doi: 10.3399/bjgp13X668195. Br J Gen Pract. 2013. PMID: 23735411 Free PMC article.
-
Fixed-Dose Combination Formulations in Solid Oral Drug Therapy: Advantages, Limitations, and Design Features.Pharmaceutics. 2024 Jan 26;16(2):178. doi: 10.3390/pharmaceutics16020178. Pharmaceutics. 2024. PMID: 38399239 Free PMC article. Review.
-
Fixed-dose combination therapy for the prevention of atherosclerotic cardiovascular diseases.Cochrane Database Syst Rev. 2017 Mar 6;3(3):CD009868. doi: 10.1002/14651858.CD009868.pub3. Cochrane Database Syst Rev. 2017. PMID: 28263370 Free PMC article.
-
Fixed-dose combination therapy for the prevention of cardiovascular disease.Cochrane Database Syst Rev. 2014 Apr 16;4(4):CD009868. doi: 10.1002/14651858.CD009868.pub2. Cochrane Database Syst Rev. 2014. Update in: Cochrane Database Syst Rev. 2017 Mar 06;3:CD009868. doi: 10.1002/14651858.CD009868.pub3. PMID: 24737108 Free PMC article. Updated.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
